ZBH Chart

1 Month

	Date	Diff	Articles
	2025-03-31	+0.82 %	Zimmer Biomet (ZBH) stock rose 0.82% due to various institutional investors adjusting their positions and favorable quarterly earnings results that exceeded expectations, alongside a recently announced dividend.
Zimmer Biomet (ZBH) stock rose 0.82% due to various institutional investors adjusting their positions and favorable quarterly earnings results that exceeded expectations, alongside a recently announced dividend.
	2025-03-28	+0.1 %	Zimmer Biomet (ZBH) stock increased by 0.1% following its acquisition of Paragon 28, Inc. for $13.00 per share in cash, which also includes a contingent value right based on future revenue milestones.
Zimmer Biomet (ZBH) stock increased by 0.1% following its acquisition of Paragon 28, Inc. for $13.00 per share in cash, which also includes a contingent value right based on future revenue milestones.
	2025-03-25	-0.77 %	Zimmer Biomet Holdings, Inc. (ZBH) stock fell by 0.77% following the announcement of its proposed buyout of Paragon 28, Inc. at a price that some analysts believe is below fair market value, leading to concerns about the adequacy of the transaction for Paragon's shareholders.
Zimmer Biomet Holdings, Inc. (ZBH) stock fell by 0.77% following the announcement of its proposed buyout of Paragon 28, Inc. at a price that some analysts believe is below fair market value, leading to concerns about the adequacy of the transaction for Paragon's shareholders.
	2025-03-24	+0.46 %	Zimmer Biomet (ZBH) stock rose by 0.46% as institutional investors, including several hedge funds, are actively adjusting their stakes in the company, signaling potential confidence in its market position, despite analysts' mixed ratings.
Zimmer Biomet (ZBH) stock rose by 0.46% as institutional investors, including several hedge funds, are actively adjusting their stakes in the company, signaling potential confidence in its market position, despite analysts' mixed ratings. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) saw a 0.46% increase in its stock price, attributed to a consensus “Hold” rating from analysts and mixed price target adjustments, including an upgrade from Stifel Nicolaus, reflecting some investor confidence despite varying assessments from different research firms.
	2025-03-20	-1 %	Zimmer Biomet (ZBH) stock dropped by 1.0% following a significant reduction in HighTower Advisors LLC's stake in the company by 14.2% during the fourth quarter, highlighting potential investor caution and volatility in institutional holdings.
Zimmer Biomet (ZBH) stock dropped by 1.0% following a significant reduction in HighTower Advisors LLC's stake in the company by 14.2% during the fourth quarter, highlighting potential investor caution and volatility in institutional holdings.
	2025-03-17	+1.65 %	Zimmer Biomet (ZBH) stock rose by 1.65% due to significant purchases by institutional investors, including a new position by Raymond James Financial, which indicates growing confidence in the company's prospects and overall stability in the medical equipment market.
Zimmer Biomet (ZBH) stock rose by 1.65% due to significant purchases by institutional investors, including a new position by Raymond James Financial, which indicates growing confidence in the company's prospects and overall stability in the medical equipment market.
	2025-03-14	+2.23 %	Zimmer Biomet (ZBH) stock rose by 2.23% as a result of several institutional investors adjusting their positions, including Victory Capital Management's significant sell-off and other firms boosting their stakes, alongside positive earnings results that exceeded expectations and favorable analyst ratings.
Zimmer Biomet (ZBH) stock rose by 2.23% as a result of several institutional investors adjusting their positions, including Victory Capital Management's significant sell-off and other firms boosting their stakes, alongside positive earnings results that exceeded expectations and favorable analyst ratings. Zimmer Biomet (ZBH) stock increased by 2.23% due to institutional investors like Atria Investments significantly boosting their holdings and a positive earnings report that surpassed analysts' expectations. Zimmer Biomet (ZBH) stock rose 2.23% likely due to positive earnings results that surpassed analysts' expectations and ongoing support from institutional investors, despite recent insider sales by company executives. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) stock increased by 2.23% due to a positive earnings report exceeding analyst expectations despite a minor downgrade in earnings estimates for Q3 2025 by Zacks Research, alongside ongoing interest from institutional investors. Zimmer Biomet (NYSE: ZBH) stock rose 2.23% largely due to increased institutional investment, with several hedge funds significantly increasing their positions in the company during the fourth quarter, reflecting growing confidence in its financial performance and future prospects.
	2025-03-13	+3.4 %	Zimmer Biomet (ZBH) stock rose by 3.4% due to a combination of positive quarterly earnings results that beat analyst expectations, continued institutional interest, and recent upgrades from several brokerages, despite some hedge funds reducing their holdings.
Zimmer Biomet (ZBH) stock rose by 3.4% due to a combination of positive quarterly earnings results that beat analyst expectations, continued institutional interest, and recent upgrades from several brokerages, despite some hedge funds reducing their holdings. Zimmer Biomet (ZBH) stock rose by 3.4% following a period where various institutional investors adjusted their holdings, demonstrating renewed interest in the company amid mixed analyst ratings and solid recent earnings performance.
	2025-03-12	-3.08 %	Zimmer Biomet Holdings, Inc. (NYSE:ZBH) shares fell by -3.08% after Zacks Research downgraded its Q1 2025 earnings per share estimates from $1.80 to $1.77, indicating concerns about the company's future profitability.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) shares fell by -3.08% after Zacks Research downgraded its Q1 2025 earnings per share estimates from $1.80 to $1.77, indicating concerns about the company's future profitability. Zimmer Biomet (ZBH) stock fell by 3.08% due to market challenges, including high costs associated with robotic-assisted surgery systems, which can inhibit adoption by smaller healthcare providers despite the growing demand for advanced surgical technologies. Zimmer Biomet's stock (ZBH) fell by 3.08% amid a legal investigation regarding its acquisition of Paragon 28, Inc., which raised concerns over potential violations of federal securities laws and fiduciary duties to shareholders.
	2025-03-11	-2.99 %	Zimmer Biomet (ZBH) stock declined by 2.99% as Steward Partners Investment Advisory LLC significantly reduced its stake in the company, selling over half of its shares, which reflects broader investor caution amidst shifting positions and analyst rating adjustments.
Zimmer Biomet (ZBH) stock declined by 2.99% as Steward Partners Investment Advisory LLC significantly reduced its stake in the company, selling over half of its shares, which reflects broader investor caution amidst shifting positions and analyst rating adjustments.